id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-335792-1yjope1j	Osho, Asishana A.	Veno-venous Extracorporeal Membrane Oxygenation for Respiratory Failure in COVID-19 Patients: Early Experience From a Major Academic Medical Center in North America	2020-05-22		.txt	text/plain	2505	125	43	SUMMARY AND BACKGROUND DATA: VV ECMO can be utilized as an advanced therapy in select patients with COVID-19 respiratory failure refractory to traditional critical care management and optimal mechanical ventilation. Anticipating a need for such therapies during the pandemic, our center created a targeted protocol for ECMO therapy in COVID-19 patients that allows us to provide this life-saving therapy to our sickest patients without overburdening already stretched resources or excessively exposing healthcare staff to infection risk. In cases where respiratory failure is extreme enough to preclude adequate gas exchange despite patient optimization and optimal mechanical ventilation, veno-venous extracorporeal membrane oxygenation (VV ECMO) may serve as an additional supportive therapy in our limited arsenal against COVID-19. Several absolute contraindications to ECMO cannulation in COVID-19 patients were identified including age >60 years, multisystem organ failure, active malignancy, pre-existing chronic cardiac, pulmonary (not including asthma) or hepatic disease, unknown or guarded neurologic status, and severe neutropenia (Absolute Neutrophil Count <1000/mm 3 ).	./cache/cord-335792-1yjope1j.txt	./txt/cord-335792-1yjope1j.txt